Positivity Rate of [18F]Fluciclovine PET/CT in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Below 1 ng/mL

Authors :: Robert Wagner
Damian Grybowski
Medhat Gabriel
Jad El Bulbul
Bital Savir-Baruch
Abhishek A. Solanki
Petra Lovrec
Source :: Molecular Imaging and Biology. 24:42-49
Publication Year :: 2021
Publisher :: Springer Science and Business Media LLC, 2021.
Abstract: Early and precise localization of recurrent prostate cancer lesions after local therapy facilitates optimal disease management. Here, we present results from a single-center study to evaluate the utility of [18F]fluciclovine PET/CT to localize prostate cancer recurrence in patients with PSA 0–

Subjects :: Cancer Research
PET-CT
medicine.medical_specialty
Lung
business.industry
Urology
Soft tissue
medicine.disease
Extraprostatic
Prostate cancer
medicine.anatomical_structure
Oncology
Prostate
medicine
Radiology, Nuclear Medicine and imaging
Lymph
business
Pelvis

Full Text Access

Tools